Merck held talks to buy Swiss biotech MoonLake for more than $3bn
US pharmaceuticals group has been looking to rebuild its pipeline before crucial cancer drug comes off-patent
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
